Xencor (XNCR) Operating Leases (2019 - 2026)
Xencor (XNCR) posted quarterly Operating Leases of $66.6 million for Q1 2026, down 1.76% year-over-year from $67.8 million in Q1 2025, and up 2.93% quarter-over-quarter from $64.7 million in Q4 2025.
Xencor (XNCR) Operating Leases (2019 - 2026) Analysis & Trends
Xencor (XNCR) has reported Operating Leases for 8 consecutive years, with $66.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Leases fell 1.76% year-over-year to $66.6 million; the TTM figure through Mar 2026 stood at $66.6 million (down 1.76% YoY), while the FY2025 annual figure was $64.7 million, down 0.92% from the prior year.
- Operating Leases rose to $66.6 million in Q1 2026 per XNCR's latest filing, from $64.7 million in the prior quarter.
- Across five years, Operating Leases topped out at $68.9 million in Q1 2024 and bottomed at $22.5 million in Q3 2022.
- Historically, Operating Leases has averaged $57.8 million across 5 years, with a median of $64.7 million in 2025.
- On a YoY basis, Operating Leases climbed as much as 1156.22% in 2022 and fell as far as 33.88% in 2022.
- Xencor's Operating Leases stood at $54.9 million in 2022, then rose by 7.46% to $59.0 million in 2023, then rose by 10.7% to $65.3 million in 2024, then dropped by 0.92% to $64.7 million in 2025, then rose by 2.93% to $66.6 million in 2026.
- Business Quant data shows XNCR's Operating Leases at $66.6 million in Q1 2026, $64.7 million in Q4 2025, and $65.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Xencor | 1.73 Bn | 1.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 65.21 Mn |
| Mar 31, 2026 | 66.63 Mn |
| Dec 31, 2025 | 64.74 Mn |
| Sep 30, 2025 | 65.33 Mn |
| Jun 30, 2025 | 67.93 Mn |
| Mar 31, 2025 | 67.82 Mn |
| Dec 31, 2024 | 65.34 Mn |
| Sep 30, 2024 | 68.67 Mn |
| Jun 30, 2024 | 68.42 Mn |
| Mar 31, 2024 | 68.89 Mn |
| Dec 31, 2023 | 59.03 Mn |
| Sep 30, 2023 | 60.76 Mn |
| Jun 30, 2023 | 54.62 Mn |
| Mar 31, 2023 | 59.24 Mn |
| Dec 31, 2022 | 54.93 Mn |
| Sep 30, 2022 | 22.54 Mn |
| Jun 30, 2022 | 33.94 Mn |
| Mar 31, 2022 | 33.96 Mn |
| Dec 31, 2021 | 33.97 Mn |
| Sep 30, 2021 | 34.09 Mn |